Literature DB >> 30503705

Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.

Christopher J Ott1, Alexander J Federation2, Logan S Schwartz3, Siddha Kasar4, Josephine L Klitgaard4, Romina Lenci4, Qiyuan Li5, Matthew Lawlor3, Stacey M Fernandes4, Amanda Souza4, Donald Polaski4, Deepti Gadi4, Matthew L Freedman4, Jennifer R Brown6, James E Bradner7.   

Abstract

Enhancer profiling is a powerful approach for discovering cis-regulatory elements that define the core transcriptional regulatory circuits of normal and malignant cells. Gene control through enhancer activity is often dominated by a subset of lineage-specific transcription factors. By integrating measures of chromatin accessibility and enrichment for H3K27 acetylation, we have generated regulatory landscapes of chronic lymphocytic leukemia (CLL) samples and representative cell lines. With super enhancer-based modeling of regulatory circuits and assessments of transcription factor dependencies, we discover that the essential super enhancer factor PAX5 dominates CLL regulatory nodes and is essential for CLL cell survival. Targeting enhancer signaling via BET bromodomain inhibition disrupts super enhancer-dependent gene expression with selective effects on CLL core regulatory circuitry, conferring potent anti-tumor activity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BET bromodomain inhibitor; PAX5; chronic lymphocytic leukemia; enhancers

Mesh:

Substances:

Year:  2018        PMID: 30503705      PMCID: PMC6298230          DOI: 10.1016/j.ccell.2018.11.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  72 in total

1.  Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia.

Authors:  Larry Mansouri; Rebeqa Gunnarsson; Lesley-Ann Sutton; Adam Ameur; Sean D Hooper; Markus Mayrhofer; Gunnar Juliusson; Anders Isaksson; Ulf Gyllensten; Richard Rosenquist
Journal:  Am J Hematol       Date:  2012-06-03       Impact factor: 10.047

2.  A probability-based approach for the analysis of large-scale RNAi screens.

Authors:  Renate König; Chih-yuan Chiang; Buu P Tu; S Frank Yan; Paul D DeJesus; Angelica Romero; Tobias Bergauer; Anthony Orth; Ute Krueger; Yingyao Zhou; Sumit K Chanda
Journal:  Nat Methods       Date:  2007-09-09       Impact factor: 28.547

3.  Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation.

Authors:  Jason D Buenrostro; M Ryan Corces; Caleb A Lareau; Beijing Wu; Alicia N Schep; Martin J Aryee; Ravindra Majeti; Howard Y Chang; William J Greenleaf
Journal:  Cell       Date:  2018-04-26       Impact factor: 41.582

4.  Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.

Authors:  Marc R Mansour; Brian J Abraham; Lars Anders; Alla Berezovskaya; Alejandro Gutierrez; Adam D Durbin; Julia Etchin; Lee Lawton; Stephen E Sallan; Lewis B Silverman; Mignon L Loh; Stephen P Hunger; Takaomi Sanda; Richard A Young; A Thomas Look
Journal:  Science       Date:  2014-11-13       Impact factor: 47.728

5.  Robust 4C-seq data analysis to screen for regulatory DNA interactions.

Authors:  Harmen J G van de Werken; Gilad Landan; Sjoerd J B Holwerda; Michael Hoichman; Petra Klous; Ran Chachik; Erik Splinter; Christian Valdes-Quezada; Yuva Oz; Britta A M Bouwman; Marjon J A M Verstegen; Elzo de Wit; Amos Tanay; Wouter de Laat
Journal:  Nat Methods       Date:  2012-09-09       Impact factor: 28.547

6.  Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

Authors:  U Klein; Y Tu; G A Stolovitzky; M Mattioli; G Cattoretti; H Husson; A Freedman; G Inghirami; L Cro; L Baldini; A Neri; A Califano; R Dalla-Favera
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

7.  Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line.

Authors:  J Lacy; W P Summers; M Watson; P M Glazer; W C Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position.

Authors:  Jason D Buenrostro; Paul G Giresi; Lisa C Zaba; Howard Y Chang; William J Greenleaf
Journal:  Nat Methods       Date:  2013-10-06       Impact factor: 28.547

9.  Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.

Authors:  Andrew W Roberts; Matthew S Davids; John M Pagel; Brad S Kahl; Soham D Puvvada; John F Gerecitano; Thomas J Kipps; Mary Ann Anderson; Jennifer R Brown; Lori Gressick; Shekman Wong; Martin Dunbar; Ming Zhu; Monali B Desai; Elisa Cerri; Sari Heitner Enschede; Rod A Humerickhouse; William G Wierda; John F Seymour
Journal:  N Engl J Med       Date:  2015-12-06       Impact factor: 91.245

10.  Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line.

Authors:  Andreas Agathangelidis; Lydia Scarfò; Federica Barbaglio; Benedetta Apollonio; Maria Teresa Sabrina Bertilaccio; Pamela Ranghetti; Maurilio Ponzoni; Gabriella Leone; Valeria De Pascali; Lorenza Pecciarini; Paolo Ghia; Federico Caligaris-Cappio; Cristina Scielzo
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

View more
  34 in total

1.  Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.

Authors:  Julio Delgado; Ferran Nadeu; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

Review 2.  Pharmacological Modulation of Transcriptional Coregulators in Cancer.

Authors:  Timothy R Bishop; Yuxiang Zhang; Michael A Erb
Journal:  Trends Pharmacol Sci       Date:  2019-05-08       Impact factor: 14.819

3.  Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Shinobu Tsuzuki; Takahiko Yasuda; Shinya Kojima; Masahito Kawazu; Koshi Akahane; Takeshi Inukai; Masue Imaizumi; Takanobu Morishita; Koichi Miyamura; Toshihide Ueno; Sivasundaram Karnan; Akinobu Ota; Toshinori Hyodo; Hiroyuki Konishi; Masashi Sanada; Hirokazu Nagai; Keizo Horibe; Akihiro Tomita; Kyogo Suzuki; Hideki Muramatsu; Yoshiyuki Takahashi; Yasushi Miyazaki; Itaru Matsumura; Hitoshi Kiyoi; Yoshitaka Hosokawa; Hiroyuki Mano; Fumihiko Hayakawa
Journal:  Blood Cancer Discov       Date:  2020-06-10

4.  Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma.

Authors:  Shivendra Singh; Ahmed Abu-Zaid; Hongjian Jin; Jie Fang; Qiong Wu; Tingting Wang; Helin Feng; Waise Quarni; Ying Shao; Lily Maxham; Alireza Abdolvahabi; Mi-Kyung Yun; Sivaraja Vaithiyalingam; Haiyan Tan; John Bowling; Victoria Honnell; Brandon Young; Yian Guo; Richa Bajpai; Shondra M Pruett-Miller; Gerard C Grosveld; Mark Hatley; Beisi Xu; Yiping Fan; Gang Wu; Eleanor Y Chen; Taosheng Chen; Peter W Lewis; Zoran Rankovic; Yimei Li; Andrew J Murphy; John Easton; Junmin Peng; Xiang Chen; Ruoning Wang; Stephen W White; Andrew M Davidoff; Jun Yang
Journal:  Sci Transl Med       Date:  2022-07-13       Impact factor: 19.319

5.  Lineage-specific rearrangement of chromatin loops and epigenomic features during adipocytes and osteoblasts commitment.

Authors:  Ruo-Han Hao; Yan Guo; Chen Wang; Fei Chen; Chen-Xi Di; Shan-Shan Dong; Qi-Long Cao; Jing Guo; Yu Rong; Shi Yao; Dong-Li Zhu; Yi-Xiao Chen; Hao Chen; Tie-Lin Yang
Journal:  Cell Death Differ       Date:  2022-07-29       Impact factor: 12.067

6.  B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells.

Authors:  Zhiquan Wang; Huihuang Yan; Justin C Boysen; Charla R Secreto; Renee C Tschumper; Dania Ali; Qianqian Guo; Jian Zhong; Jiaqi Zhou; Haiyun Gan; Chuanhe Yu; Diane F Jelinek; Susan L Slager; Sameer A Parikh; Esteban Braggio; Neil E Kay
Journal:  Blood Cancer J       Date:  2022-07-01       Impact factor: 9.812

7.  Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.

Authors:  Seiko Yoshino; Takashi Yokoyama; Yoshitaka Sunami; Tomoko Takahara; Aya Nakamura; Yukari Yamazaki; Shuichi Tsutsumi; Hiroyuki Aburatani; Takuro Nakamura
Journal:  Blood       Date:  2021-01-07       Impact factor: 22.113

8.  Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.

Authors:  Sylvan C Baca; David Y Takeda; Ji-Heui Seo; Justin Hwang; Sheng Yu Ku; Rand Arafeh; Taylor Arnoff; Supreet Agarwal; Connor Bell; Edward O'Connor; Xintao Qiu; Sarah Abou Alaiwi; Rosario I Corona; Marcos A S Fonseca; Claudia Giambartolomei; Paloma Cejas; Klothilda Lim; Monica He; Anjali Sheahan; Amin Nassar; Jacob E Berchuck; Lisha Brown; Holly M Nguyen; Ilsa M Coleman; Arja Kaipainen; Navonil De Sarkar; Peter S Nelson; Colm Morrissey; Keegan Korthauer; Mark M Pomerantz; Leigh Ellis; Bogdan Pasaniuc; Kate Lawrenson; Kathleen Kelly; Amina Zoubeidi; William C Hahn; Himisha Beltran; Henry W Long; Myles Brown; Eva Corey; Matthew L Freedman
Journal:  Nat Commun       Date:  2021-03-30       Impact factor: 14.919

9.  Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.

Authors:  Junyan Lu; Ester Cannizzaro; Fabienne Meier-Abt; Sebastian Scheinost; Peter-Martin Bruch; Holly Ar Giles; Almut Lütge; Jennifer Hüllein; Lena Wagner; Brian Giacopelli; Ferran Nadeu; Julio Delgado; Elías Campo; Maurizio Mangolini; Ingo Ringshausen; Martin Böttcher; Dimitrios Mougiakakos; Andrea Jacobs; Bernd Bodenmiller; Sascha Dietrich; Christopher C Oakes; Thorsten Zenz; Wolfgang Huber
Journal:  Nat Cancer       Date:  2021-07-01

Review 10.  Super-enhancer-mediated core regulatory circuitry in human cancer.

Authors:  Yuan Jiang; Yan-Yi Jiang; De-Chen Lin
Journal:  Comput Struct Biotechnol J       Date:  2021-05-05       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.